<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Protein aggregation in Huntington's disease - Health AI Hub</title>
    <meta name="description" content="This paper investigates protein aggregation in Huntington's disease (HD), proposing two primary mechanisms: hydrogen bonding via polar-zipper formation and cova">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>Protein aggregation in Huntington's disease</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2511.04174v1" target="_blank">2511.04174v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2025-11-06
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Guylaine Hoffner, Philippe Djian
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> q-bio.BM, q-bio.NC
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 0.98 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2511.04174v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="http://arxiv.org/pdf/2511.04174v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">This paper investigates protein aggregation in Huntington's disease (HD), proposing two primary mechanisms: hydrogen bonding via polar-zipper formation and covalent bonding catalyzed by transglutaminase. While cell culture models indicate hydrogen bonds are the main stabilizers with likely covalent contributions, the crucial nature of these bonds in the brains of HD patients remains unknown, posing a significant challenge for therapeutic development.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>Understanding the precise molecular mechanisms of protein aggregation in Huntington's disease is paramount, as it directly dictates the potential targets and strategies for developing disease-modifying therapies to prevent neuronal death.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>Not applicable. The paper describes fundamental biological mechanisms and their implications for therapy, without mentioning any AI methodologies, computational models, data analysis using AI, or AI-driven applications.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>Huntington's disease pathogenesis involves a toxic gain of function from expanded polyglutamine in the huntingtin protein, leading to protein aggregation.</li>
                    
                    <li>Protein aggregation is considered a primary cause of neuronal death in HD.</li>
                    
                    <li>Two main mechanisms for protein aggregation stabilization are proposed: non-covalent hydrogen bonding (polar-zipper formation) and covalent bonding through transglutaminase-catalyzed cross-linking.</li>
                    
                    <li>In cell culture models of HD, aggregates are predominantly stabilized by hydrogen bonds, although covalent bonds are also considered likely to occur.</li>
                    
                    <li>A critical knowledge gap exists regarding the specific nature of the bonds stabilizing aggregates in the brains of patients with Huntington's disease.</li>
                    
                    <li>Understanding the type of bond stabilizing aggregates is posited as a fundamental question, directly influencing the design of effective therapeutic strategies for HD.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>The paper references observations made in 'cell culture models' of Huntington's disease to study the nature of protein aggregates and their stabilizing bonds.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>In cell culture models of Huntington's disease, protein aggregates are primarily stabilized by hydrogen bonds, with a probable contribution from covalent bonds. However, the exact nature of these stabilizing bonds within human HD patient brains remains undetermined.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>Identifying the dominant type of bond stabilizing aggregates in human brains would enable the development of highly specific therapeutic interventions, such as small molecules or enzyme inhibitors, designed to disrupt these particular bonds or prevent their formation, thereby potentially halting or slowing neuronal degeneration in HD patients.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>The major limitation highlighted is the lack of knowledge concerning the actual nature and types of bonds that stabilize protein aggregates within the brains of patients with Huntington's disease, indicating that findings from cell culture models may not fully extrapolate to the in vivo human condition.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>The paper strongly implies that future research must focus on elucidating the nature of bonds stabilizing aggregates specifically within the brains of HD patients, as this knowledge is deemed essential for guiding and conditioning effective therapeutic approaches.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Neurology</span>
                    
                    <span class="tag">Neurogenetics</span>
                    
                    <span class="tag">Molecular Medicine</span>
                    
                    <span class="tag">Pharmacology</span>
                    
                    <span class="tag">Neuroscience</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">Huntington's disease</span>
                    
                    <span class="tag tag-keyword">protein aggregation</span>
                    
                    <span class="tag tag-keyword">polyglutamine</span>
                    
                    <span class="tag tag-keyword">huntingtin</span>
                    
                    <span class="tag tag-keyword">hydrogen bonding</span>
                    
                    <span class="tag tag-keyword">covalent bonding</span>
                    
                    <span class="tag tag-keyword">transglutaminase</span>
                    
                    <span class="tag tag-keyword">neuronal death</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">The presence of an expanded polyglutamine produces a toxic gain of function
in huntingtin. Protein aggregation resulting from this gain of function is
likely to be the cause of neuronal death. Two main mechanisms of aggregation
have been proposed: hydrogen bonding by polar-zipper formation and covalent
bonding by transglutaminase-catalyzed cross-linking. In cell culture models of
Huntington's disease, aggregates are mostly stabilized by hydrogen bonds, but
covalent bonds are also likely to occur. Nothing is known about the nature of
the bonds that stabilize the aggregates in the brain of patients with
Huntington's disease. It seems that the nature of the bond stabilizing the
aggregates is one of the most important questions, as the answer would
condition the therapeutic approach to Huntington's disease.</p>
            </section>

            

            
            <section class="paper-section">
                <h2>Journal Reference</h2>
                <p>Biochimie, 2002, 84 (4), pp.273-278</p>
            </section>
            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>